VarfarinApp

Warfarin reduces the incidence of thromboembolic events by an average of 64% and mortality in patients at high risk of stroke.
Warfarin has been used for more than 70 years in medical practice, its effectiveness has been proven in several clinical trials and its safety is related to keeping the patient within the therapeutic range. Good expertise in patient care, including knowledge of drug interactions, pharmacology, dose adjustments, perioperative and bleeding management, reduces the risk of complications and adds confidence to healthcare professionals in treating patients.
With the experience accumulated during the years of clinical care, it is imperative to share information so that the greatest possible number of patients can be helped and benefited.
Many physicians have difficulties in managing warfarin due to its pharmacokinetic and pharmacodynamic characteristics and often give up on offering the best treatment to avoid thromboembolic events due to this limitation. A tool that assists these professionals in the administration of the drug can positively impact the reduction of bleeding complications related to this substance.
The technological evolution experienced in recent years has allowed the development of numerous applications with medical content at the national and international level. These tools facilitate the transmission of knowledge more quickly, increasing safety for healthcare professionals and patients.
In view of this scenario, the VarfarinApp was developed for the platform, with content aimed at physicians on the management of warfarin.